Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

por Stefoni, V, Casadei, B, Bottelli, C, Gaidano, G, Ciochetto, C, Cabras, M G, Ansuinelli, M, Argnani, L, Broccoli, A, Gandolfi, L, Pellegrini, C, Zinzani, P L
Publicado 2016

P1098: OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN MAINTENANCE TREATMENT WITH ANTICD20 MONOCLONAL ANTIBODIES IN SARS-COV2 ERA: RESULTS FROM A MULTICENTER, RETROSPECTIVE- PROSPECTIVE...

por Castellino, A., Castellino, C., Boccomini, C., Clerico, M., Nicoli, P., Vanazzi, A., Fanelli, F., Perrone, T., Marchesi, F., Cocito, F., Merli, M., Bigliardi, S., Mecacci, B., Bozzoli, V., Margiotta-Casaluci, G., Meli, E., Anastasia, A., Farina, L., Annibali, O., Gottardi, D., Zanni, M., Conconi, A., Ciochetto, C., Cenfra, N., Rotondo, F., Ratotti, S., Cuneo, A., Selleri, C., Galimberti, S., Massaia, M.
Publicado 2022